Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
Clinical trial NCT04256941 · TERMINATED
Trial details
- NCT number
- NCT04256941
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2023-09-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.